TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers

IF 2.8 4区 医学 Q2 PATHOLOGY
Melika Golozar , Ali Valipour Motlagh , Mohammad Mahdevar , Maryam Peymani , Kolsoum InanlooRahatloo , Kamran Ghaedi
{"title":"TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers","authors":"Melika Golozar ,&nbsp;Ali Valipour Motlagh ,&nbsp;Mohammad Mahdevar ,&nbsp;Maryam Peymani ,&nbsp;Kolsoum InanlooRahatloo ,&nbsp;Kamran Ghaedi","doi":"10.1016/j.yexmp.2024.104890","DOIUrl":null,"url":null,"abstract":"<div><p>Alterations in the expression of certain genes could be associated with both patient mortality rates and drug resistance. This study aimed to identify genes in colorectal cancer (CRC) that potentially serve as hub genes influencing patient survival rates. RNA-Seq data were downloaded from the cancer genome atlas database, and differential expression analysis was performed between tumors and healthy controls. Through the utilization of univariate and multivariate Cox regression analyses, in combination with the MCODE clustering module, the genes whose expression changes were related to survival rate and the hub genes related to them were identified. The mortality risk model was computed using the hub genes. CRC samples and the RT-qPCR method were utilized to confirm the outcomes. PharmacoGx data were employed to link the expression of potential genes to medication resistance and sensitivity. The results revealed the discovery of seven hub genes, which emerged as independent prognostic markers. These included <em>HOXC6</em>, <em>HOXC13</em>, <em>HOXC8</em>, and <em>TBX15</em>, which were associated with poor prognosis and overexpression, as well as <em>SDHB</em>, <em>COX5A</em>, and <em>UQCRC1</em>, linked to favorable prognosis and downregulation. Applying the risk model developed with the mentioned genes revealed a markedly higher incidence of deceased patients in the high-risk group compared to the low-risk group. RT-qPCR results indicated a decrease in <em>SDHB</em> expression and an elevation in <em>TBX15</em> levels in cancer samples relative to adjacent healthy tissue. Also, PharmacoGx data indicated that the expression level of <em>SDHB</em> was correlated with drug sensitivity to Crizotinib and Dovitinib. Our findings highlight the potential association between alterations in the expression of genes such as <em>HOXC6</em>, <em>HOXC13</em>, <em>HOXC8</em>, <em>TBX15</em>, <em>SDHB</em>, <em>COX5A</em>, and <em>UQCRC1</em> and increased mortality rates in CRC patients. As revealed by the PPI network, these genes exhibited the most connections with other genes linked to survival.</p></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"136 ","pages":"Article 104890"},"PeriodicalIF":2.8000,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0014480024000091/pdfft?md5=81cba468dad9389365dfdf0369be2e8e&pid=1-s2.0-S0014480024000091-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and molecular pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014480024000091","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Alterations in the expression of certain genes could be associated with both patient mortality rates and drug resistance. This study aimed to identify genes in colorectal cancer (CRC) that potentially serve as hub genes influencing patient survival rates. RNA-Seq data were downloaded from the cancer genome atlas database, and differential expression analysis was performed between tumors and healthy controls. Through the utilization of univariate and multivariate Cox regression analyses, in combination with the MCODE clustering module, the genes whose expression changes were related to survival rate and the hub genes related to them were identified. The mortality risk model was computed using the hub genes. CRC samples and the RT-qPCR method were utilized to confirm the outcomes. PharmacoGx data were employed to link the expression of potential genes to medication resistance and sensitivity. The results revealed the discovery of seven hub genes, which emerged as independent prognostic markers. These included HOXC6, HOXC13, HOXC8, and TBX15, which were associated with poor prognosis and overexpression, as well as SDHB, COX5A, and UQCRC1, linked to favorable prognosis and downregulation. Applying the risk model developed with the mentioned genes revealed a markedly higher incidence of deceased patients in the high-risk group compared to the low-risk group. RT-qPCR results indicated a decrease in SDHB expression and an elevation in TBX15 levels in cancer samples relative to adjacent healthy tissue. Also, PharmacoGx data indicated that the expression level of SDHB was correlated with drug sensitivity to Crizotinib and Dovitinib. Our findings highlight the potential association between alterations in the expression of genes such as HOXC6, HOXC13, HOXC8, TBX15, SDHB, COX5A, and UQCRC1 and increased mortality rates in CRC patients. As revealed by the PPI network, these genes exhibited the most connections with other genes linked to survival.

结直肠癌中 TBX15 和 SDHB 的表达变化可作为潜在的预后生物标志物。
某些基因表达的改变可能与患者死亡率和耐药性有关。本研究旨在确定结直肠癌(CRC)中可能作为影响患者生存率的枢纽基因的基因。研究人员从癌症基因组图谱数据库下载了 RNA-Seq 数据,并对肿瘤和健康对照组进行了差异表达分析。通过单变量和多变量 Cox 回归分析,并结合 MCODE 聚类模块,确定了表达变化与生存率相关的基因以及与之相关的枢纽基因。利用中心基因计算死亡率风险模型。利用 CRC 样本和 RT-qPCR 方法确认结果。利用 PharmacoGx 数据将潜在基因的表达与耐药性和敏感性联系起来。结果显示,发现了七个作为独立预后标记的中心基因。这些基因包括与不良预后和过表达相关的 HOXC6、HOXC13、HOXC8 和 TBX15,以及与良好预后和下调相关的 SDHB、COX5A 和 UQCRC1。应用上述基因建立的风险模型发现,与低风险组相比,高风险组死亡患者的发生率明显较高。RT-qPCR 结果显示,与邻近的健康组织相比,癌症样本中 SDHB 的表达下降,TBX15 的水平升高。此外,PharmacoGx 数据显示,SDHB 的表达水平与克唑替尼和多韦替尼的药物敏感性相关。我们的研究结果突显了 HOXC6、HOXC13、HOXC8、TBX15、SDHB、COX5A 和 UQCRC1 等基因表达的改变与 CRC 患者死亡率升高之间的潜在关联。PPI 网络显示,这些基因与其他与生存相关的基因之间的联系最多。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
8.90
自引率
0.00%
发文量
78
审稿时长
11.5 weeks
期刊介绍: Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature''s most jealously guarded secrets on the pathologic basis of disease. Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信